Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prediction of cancer treatment response from histopathology images through imputed transcriptomics.

Autor: Hoang DT; Biological Data Science Institute, College of Science, Australian National University, Canberra, ACT, Australia., Dinstag G; Pangea Biomed Ltd., Tel Aviv, Israel., Hermida LC; Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.; Tumor Microenvironment Center, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA., Ben-Zvi DS; Pangea Biomed Ltd., Tel Aviv, Israel., Elis E; Pangea Biomed Ltd., Tel Aviv, Israel., Caley K; Biological Data Science Institute, College of Science, Australian National University, Canberra, ACT, Australia., Sammut SJ; Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Sinha S; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Sinha N; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Dampier CH; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Stossel C; Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel., Patil T; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Rajan A; Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Lassoued W; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Strauss J; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Bailey S; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Allen C; Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Redman J; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Beker T; Pangea Biomed Ltd., Tel Aviv, Israel., Jiang P; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Golan T; Oncology Institute, Sheba Medical Center at Tel-Hashomer, Tel Aviv University, Tel Aviv, Israel., Wilkinson S; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Sowalsky AG; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Pine SR; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Caldas C; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK., Gulley JL; Genitourinary Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Aharonov R; Pangea Biomed Ltd., Tel Aviv, Israel., Stone EA; Biological Data Science Institute, College of Science, Australian National University, Canberra, ACT, Australia., Ruppin E; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

Publikováno v: Research square [Res Sq] 2023 Sep 15. Date of Electronic Publication: 2023 Sep 15.